19
Views
5
CrossRef citations to date
0
Altmetric
Original Article

Serum CA-125 concentration in endometriosis patients: Role of pelvic and peritoneal irritation

, , , &
Pages 27-31 | Published online: 07 Jul 2009

References

  • Strathy J. H., Molgaard C. A., Coulam C. B., Melton L. J. Endometriosis and infertility: a laparoscopic study of endometriosis among fertile and infertile women. Fertil. Steril. 1982; 38: 667–72
  • Kirshon B., Poindexter A. N., Fast J. Endometriosis in multiparous women. J. Reprod. Med. 1989; 34: 215–17
  • Dorffler P., Caffier H., Steck T. Serum concentrations of CA-125 in patients with endometriosis. Arch. Gynecol. Obstet. 1991; 250: 1017–19
  • Pittaway D. E. The use of serial CA-125 concentrations to monitor endometriosis in infertile women. Am. J. Obstet. Gynecol. 1990; 63: 1032–6
  • Gurgan T., Kisnisci H., Yarali H., Aksu T., Zeyncloglu H., Develioglu O. Serum and peritoneal fluid CA-125 levels in early stage endometriosis. Gynecol. Obstet. Invest. 1990; 30: 105–8
  • Niloff J. M., Knapp R. C., Schaetzl E., Reynolds C., Bast R. G., Jr. CA-125 antigen levels in obstetrics and gynecologic patients. Obstet. Gynecol. 1984; 64: 703–7
  • Barbieri R. L., Niloff J. M., Bast R. C., Jr, Schaetzl E., Kistner R. W., Knapp R. C. Elevated serum concentrations of CA-125 in patients with advanced endometriosis. Fertil. Steril. 1986; 45: 630–4
  • Pittaway D. E., Fayez J. A. Serum CA-1125 antigen levels increase during menses. Am. J. Obstet. Gynecol. 1987; 156: 75–6
  • Masahashi T., Matsuzawa K., Ohsawa M., Narita O., Asai T., Ishihara M. Serum CA-125 levels in patients with endometriosis: changes in CA-125 levels during menstruation. Obstet. Gynecol. 1988; 72: 328–31
  • Fedele L., Arcaini L., Baglioni A., Bianchi S., Menard S. What is the source of elevated serum levels of CA-125 in patients with endometriosis?. Eur. J. Obstet. Gynecol. Reprod. Biol. 1989; 33: 247–52
  • Fraussen A. M. H.W., Van Der Heijden P. F. M., Thomas C. M. G., Doesburg W. H., Willemsen W. N. P., Rolland R. On the origin and significance of serum CA-125 concentrations in 97 patients with endometriosis before, during and after buserelin acetate, nafarelin, or danazol. Fertil. Steril. 1992; 57: 974–9
  • Kauppila A., Talimaa S., Ronneberg J., Vuori J. Placebo-controlled study on serum concentrations of CA-125 before and after treatment of endometriosis with danazol or high-dose medroxyprogesterone acetate alone or after surgery. Fertil. Steril. 1988; 49: 37–41
  • Marana R., Muzii L., Muscatello P., Lanzone A., Caruso A., Dell'Acqua S., Mancuso S. Gonadotrophin releasing hormone agonist (buserelin) in the treatment of endometriosis: changes in the extent of the disease and in CA-125 serum levels after 6-month therapy. Br. J. Obstet. Gynaecol. 1990; 97: 1016–19
  • American Fertility Society. Revised American Fertility Society Classification of Endometriosis: 1985. Fertil. Steril. 1985; 43: 351–2

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.